Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Francis Michon is active.

Publication


Featured researches published by Francis Michon.


The Journal of Infectious Diseases | 1999

The Role of B/T Costimulatory Signals in the Immunopotentiating Activity of Neisserial Porin

Fiona G. Mackinnon; Yu Ho; Milan S. Blake; Francis Michon; Anil Chandraker; Mohammed H. Sayegh; Lee M. Wetzler

A T cell-dependent immune response to group C meningococcal capsular polysaccharide (CPS) can be elicited when CPS is conjugated to the class 3 neisserial porin (CPS-porin). Treatment of CPS-porin-immunized mice with B7-2 blocking monoclonal antibody (MAb) caused a dramatic reduction in the CPS-specific IgG response, treatment with anti-B7-1 MAb had no effect, and concurrent blockade of B7-1 and B7-2 resulted in a synergistic abrogation of the CPS-specific IgG response while the CPS IgM response was unaffected. Anti-CD40L MAb treatment caused a significant reduction of both CPS-specific IgG and IgM levels. In contrast, blockade of CTLA4 interactions resulted in increases in both CPS IgG and IgM responses in CPS-porin-immunized mice. These data support the hypothesis that the ability of neisserial porins to improve the immune response to poorly immunogenic antigens (e.g., polysaccharides) is related to porin-induced increases in B7-2 expression on antigen-presenting cells and enhanced B/T cell interactions.


The Journal of Infectious Diseases | 1997

Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman Primates

Peter C. Fusco; Francis Michon; Joseph Y. Tai; Milan S. Blake


Archive | 1999

Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide

Francis Michon; Chun-Hsien Huang; Catherine Uitz


Archive | 1998

Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines

Francis Michon; Milan S. Blake


Archive | 1996

Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof

Francis Michon; Catherine Uitz; Joseph Y. Tai


Archive | 2003

Chimeric multivalent polysaccharide conjugate vaccines

Francis Michon; John Kim; Arun Sarkar; Catherine Uitz


Archive | 1998

Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide

Milan S. Blake; Francis Michon; Peter C. Fusco; Iver Heron


Archive | 2004

Carrier proteins for vaccines

John Kim; Francis Michon


Archive | 2007

Method for purifying polysaccharides

Francis Michon; Catherine Uitz


Archive | 2008

Modified Polysaccharides for Conjugate Vaccines

Francis Michon; Arun Sarkar

Collaboration


Dive into the Francis Michon's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anil Chandraker

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mohammed H. Sayegh

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge